Copper-responsive intracellular ATP7B trafficking is critical to maintain copper balance 9 in mammalian hepatocytes and thus organismal copper levels. The COMMD1 protein binds 10 both the ATP7B copper transporter and phosphatidylinositol (4,5)-bisphosphate (PtdIns(4,5)P2), 11 while COMMD1 loss causes hepatocyte copper accumulation. Although it is clear that 12 COMMD1 is included in endocytic trafficking complexes, a direct function for COMMD1 in 13 ATP7B trafficking has not been defined. In this study, experiments using quantitative reveal that 14 COMMD1 modulates the copper-responsive ATP7B trafficking through recruitment to 15 PtdIns(4,5)P2. Decreased COMMD1 abundance results in loss of ATP7B from lysosomes and 16 the trans-Golgi network (TGN) in high copper conditions, while excess expression of COMMD1 17 also disrupts ATP7B trafficking and TGN structure. Overexpression of COMMD1 mutated to 18 inhibit PtdIns(4,5)P2 binding has little impact on ATP7B trafficking. A mechanistic PtdIns(4,5)P2-19 mediated function for COMMD1 is proposed that is consistent with decreased cellular copper 20 export due to disruption of the ATP7B trafficking itinerary and accumulation in the early 21 endosome when COMMD1 is depleted. PtdIns(4,5)P2 interaction with COMMD1 as well as 22 COMMD1 abundance may both be important in maintenance of specific membrane protein 23 trafficking pathways. 24
INTRODUCTION 30
Transmembrane and membrane-associated proteins are critical components of the cell 31 plasma membrane as well as organelles, where transport, catalytic activity, signaling and 32 intracellular trafficking must be regulated based on cell physiologic state. Therefore, the proper 33 function and localization of these proteins is critical to the wellbeing of the cell and to the overall 34 health of the organism. The presence and abundance of proteins at the cell surface is regulated 35 by (1) the secretion of proteins to the PM (a process known as exocytosis or anterograde 36 trafficking) and (2) the internalization of proteins at the PM for degradation or recycling (a 37 process known as endocytosis or retrograde trafficking). Proteins following the exocytic pathway 38 leave the trans-Golgi network (TGN) and travel directly to the PM in secretory vesicles. ATP7B at the TGN in the mouse hepatoma cell line, Hepa 1-6, when cells were treated with a 81 high copper for 24 hours, then exposed to a copper chelator, implying a function in retrograde 82 trafficking (Miyayama et al., 2010). However, the specific function of COMMD1 in ATP7B 83 trafficking, and thus in regulating cellular copper export, remains unclear. 84
In this study, we tested the hypothesis that the role of COMMD1 in copper homeostasis 85 is through modulation of the ATP7B trafficking itinerary. Quantitative immunofluorescence 86 microscopy was used to monitor ATP7B subcellular localization in the HepG2 hepatoma cell 87 line. COMMD1 impacts ATP7B trafficking in cells, where reduced levels of COMMD1 result in a 88 loss of ATP7B colocalized with lysosomes as well as at the TGN, and an accumulation of 89 ATP7B associated with retromer at the EE. Overexpression of COMMD1 also promoted mis-90 localization of ATP7B, while expression of COMMD1 variants defective in PtdIns(4,5)P2 binding 91 diminished this effect. Taken together, these data illustrate the functional role of COMMD1 to 92 maintain ATP7B trafficking fidelity and indicate the importance of COMMD1 interaction with 93 PtdIns(4,5)P2 to exert effects on ATP7B. These observations reveal new potential functional 94 roles for COMMD proteins and specific interactions with signaling lipids in fidelity of membrane 95 protein trafficking. 96
97

RESULTS
98
Quantitative colocalization monitors ATP7B redistribution in response to copper 99 exposure 100
A quantitative colocalization approach was used to monitor the copper-responsive 101 trafficking itinerary for ATP7B in HepG2 cells. ATP7B is known to localize at the TGN where it 102 functions to transport copper into the lumen for biosynthesis of secreted cuproproteins 103 Representative images with approximately median colocalization values are shown in 116 ( Fig. 1A,B ). Both Manders values indicate that the ratio of ATP7B localized with the TGN 117 remained constant under all copper treatments (Fig. 1C,D) . The Pearson coefficients also 118 indicate the variance in relation to the TGN does not change with the exception of a slight 119 insignificant increase under low copper (Fig. 1E) . In contrast, the ATP7B lysosomal pool 120 showed a significant response to Cu, with increased mean values for both Manders and 121
Pearson coefficients when treated with 10, 100, and 200 µM copper and decreased values 122 when treated with the copper chelator tetrathiomolybdate (TTM) compared to basal media ( Fig.  123 1F-H). This, along with the observation that localization remained constant at the TGN indicates 124 that ATP7B synthesis is likely upregulated under high copper, and that the increase in the pool 125 is shifted toward the lysosomes. Under low copper conditions excess ATP7B leaves lysosomes. 126
Taken together, these data demonstrate that copper-responsive ATP7B distribution can 127 be quantified by 3-D colocalization analysis. Furthermore, ATP7B localization is not binary-the 128 data indicate continuous trafficking between various cellular compartments. These results 129 support a trafficking itinerary where the cell responds to changes in copper levels by adjusting 130 the proportion of ATP7B localized at a specific target compartment: when cellular copper levels 131 decrease, the lysosomal pool of ATP7B decreases; when copper levels increase through 132 addition of 10, 100, or 200 µM Cu to the media, ATP7B is directed to the lysosome. 133
COMMD1 is a modifier of ATP7B localization 134
Bedlington Terriers with a loss-of-function mutation in both alleles of COMMD1 suffer 135 copper toxicosis due to an impaired ability to excrete biliary copper (Van De Sluis et al., 2002) . 136
Furthermore, liver-specific COMMD1 knockout mice fed a copper-enriched diet had increased 137 intrahepatic copper levels compared to control mice (Vonk et al., 2011) . Therefore, we 138 determined the impact of COMMD1 depletion by siRNA on copper-responsive ATP7B 139
trafficking. 140
We found that ATP7B colocalization with the TGN increased under low copper 141 conditions in cells with decreased COMMD1 expression as compared to control cells ( Fig. 2A Replicate wells were additionally treated with chloroquine and MG132 to prevent protein 153 degradation. Chloroquine functions to prevent endosomal acidification thereby preventing fusion 154 of endosomes and lysosomes. Furthermore, it increases lysosomal pH, inhibiting protein 155 degradation. MG132 was added to prevent degradation via proteasomes. Under these 156 conditions, colocalization between ATP7B and lysosomes was not significantly different under 157 high or low copper conditions in cells with depleted COMMD1 as compared to the control. 158 ATP7B colocalization with the TGN was also not significantly different in cells treated with high 159 copper. However, when treated with TTM, cells with depleted COMMD1 showed a significant 160 (P=0.0195) increase in the Pearson coefficient, indicating increased association between 161 ATP7B and the TGN (Fig. 3) . However, Manders 1 and 2 were not significantly different and 162 therefore the proportion of ATP7B localized with TGN46 and vice-versa did not change. 163
Taken together, these results indicate that COMMD1 has an important role in 164 maintaining the ATP7B trafficking itinerary. In cells with reduced COMMD1 expression and 165 treated with TTM, the amount of ATP7B at the TGN remained constant while the proportion of 166 the cellular pool increased, indicating a decrease in the trafficking fraction of ATP7B. The 167 lysosomal pool remained unchanged under these same conditions. Alternatively, when 168 COMMD1-depleted cells were treated with high copper, the amount of ATP7B associated with 169 the both the TGN and lysosome significantly decreased as did the proportion of cellular ATP7B 170 associated with these compartments. This indicates that ATP7B trafficking induced by excess 171 cellular copper levels is altered by depletion of COMMD1, with ATP7B potentially trapped in 172 another compartment. When fusion of endosomes and lysosomes is blocked with chloroquine, 173 the observed shifts in ATP7B distribution are lost. This suggests that COMMD1 is important to 174 direct ATP7B to the recycling pathway in the EE. Thus, when COMMD1 is knocked down, 175 ATP7B may be directed to the lysosomal degradation pathway, or it might be trapped in the 176 endosome. 177
ATP7B accumulates in endosomes in COMMD1-depleted cells 178
The Burstein group reported that COMMD1 forms a novel complex with coiled-coil 179 domain-containing protein 22 (CCDC22), coiled-coil domain-containing protein 93 (CCDC93) 180 and C16orf62. They suggested this COMMD/CCDC22/CCDC93 (CCC) complex is recruited by 181 treated with TTM or CuCl2 as above. COMMD1-depleted cells grown in TTM showed a dramatic 187 increase (p-value < 0.0001) in ATP7B:VPS35 colocalization for all three coefficients (Fig. 4) . In 188 cells treated with 200 µM CuCl2, COMMD1 attenuation did not significantly increase the 189 Pearson coefficient, however both Manders 1 and 2 were again dramatically increased. ATP7B 190 accumulation with VPS35 in these conditions indicates that COMMD1 is important for ATP7B 191 exit from the early endosome and further implicates COMMD1 in ATP7B retrograde trafficking. Since decreased cellular levels of COMMD1 modulated ATP7B trafficking in a dose-209 dependent manner, we tested the hypothesis that excess COMMD1 would also impact ATP7B 210 localization. Using an inducible system to increase cellular COMMD1 levels, cells 211 overexpressing wild type COMMD1 under low copper conditions had no significant change in 212 ATP7B colocalization at the TGN. Under high copper conditions, overexpression of wild type 213 COMMD1 resulted in a significant decrease in the Pearson coefficient for ATP7B and the TGN, 214
indicating an impact on trafficking when copper levels are high (Fig. 6) . 215
A study analyzing at atypical phenotypes of Wilson disease revealed a patient with a 216 missense mutation in COMMD1 resulting in an amino acid change of threonine 174 to 217 methionine (T174M). This patient exhibited unusually severe early onset Wilson disease (Gupta 218 et al., 2010). The T174M mutation is in close proximity to two positively charged residues K167 219 and K173 (Fig. 7A) , which are key targets for PtdIns interaction based on structural models of 220 COMMD1 (Burkhead et al., 2009; Healy et al., 2018). We analyzed COMMD1 wild type and 221 mutant affinities for a soluble PtdIns(4,5)2 by intrinsic fluorescence quenching and observed a 222 small decrease in in vitro PtdIns(4,5)2 affinity for T174M compared with wild type, and a 223 substantial (5-fold) decrease in PtdIns(4,5)2 affinity in the K167E/K173E mutant (Fig. 7B) . In 224 cells, overexpression of either T174M and K167E/K173E mutants resulted in a significant 225 reduction in the Pearson coefficient for ATP7B with the TGN under TTM or high copper 226 treatments (Fig. 6I,L) . The Manders M1 and M2 distributions were also shifted down (Fig.  227   6G,H,J,K) ; however, only M1 (TGN46colocalized/TGN46, or the amount of ATP7B localized at the 228 TGN) decreased significantly. Similar to the wild type, expression of COMMD1 T174M induced 229 a significant decrease in Pearson for ATP7B:lysosomes under high copper but only a minimal 230 shift in the distribution under low copper conditions (Fig. 6C,F) . However, expression of 231 COMMD1 K167E/K173E had no effect on the localization of ATP7B under either treatment as 232 compared to non-transfected cells (Fig. 6A,B,D,E) , indicating that PtdIns(4,5)2 binding is 233 important in COMMD1 modulation of ATP7B trafficking. ). Therefore, we tested the hypothesis that modification to cellular 239 PtdIns(4,5)2 levels will affect ATP7B localization by overexpression of PtdIns(4,5)2-modifying 240 enzymes. ADP-ribosylation factor (ARF) 6 regulates trafficking between endosomes and the 241 plasma membrane. Aikawa and Martin, (2003) found that expression of the constitutively active 242
GTPase-defective ARF6 Q67L mutant redistributes PtdIns(4,5)2 from the plasma membrane to 243 endosomes. If COMMD1 is recruited to endosomes by PtdIns(4,5)2, it is expected that more 244 ATP7B would remain in the recycling pool. Alternatively, the overexpression of a PtdIns(4,5)2-5-245 phosphatase should deplete cellular PtdIns(4,5)2 levels, resulting in more ATP7B being directed 246 towards degradation. Finally, the Pleckstrin homology domain (PH domain) of Phospholipase C 247 delta has also been shown to bind with high specificity to PtdIns(4,5)2 (Várnai and Balla, 1998) . 248
Though the binding affinity of the PH domain may be lower than that of COMMD1, PH-domain 249 overexpression might compete with COMMD1 for PtdIns(4,5)2 binding sites and shift the 250 distribution of the ATP7B. Thus, to determine how modulation of PtdIns(4,5)2 affected ATP7B 251 localization, HepG2 cells were transfected with plasmids to express ARF6 Q67L , PtdIns(4,5)-5-252 phosphatase, PLCd PH domain-GFP fusion, or GFP as a control and treated cells with TTM or 253
Cu as above. 254
In cells expressing ARF6 Q67L under low copper (TTM) conditions, both the Pearson and 255 M1 coefficients ATP7B/TGN46 colocalization were significantly decreased as compared to the 256 control cell population ( Fig. 8 A-C) . When treated with 200 µM Copper, there was an increase in 257 M2, but M1 and Pearson showed no significant change (Fig. 8D-F) . There was no change in 258 colocalization between ATP7B and LAMP1 in cells expressing ARF6 Q67L with high or low copper 259 conditions (Fig. 8G-L) . Cells expressing PtdIns(4,5)-5-phosphatase lost all TGN46 signal (Fig.  260   8A-F) . This is likely due to an increase in PI(4)P at the trans-Golgi. PI(4)P is known to recruit 261 clathrin adaptor AP-1 to the trans-Golgi (Wang et al., 2003) , which functions to sort proteins for 262 trafficking from the trans-Golgi to endosomes and lysosomes. Therefore, it is likely TGN46 263 anterograde trafficking was dramatically increased, transporting all TGN46 to the endosomes 264 and eventually the lysosome. This likely also impacted protein sorting and trafficking for many 265 other cargo proteins, including ATP7B. These observations suggest that artificially modulating 266 PtdIns(4,5)P2 levels in cells is overall deleterious and impacts broad cellular functions. Thus, 267 this data was not used to assess how interactions between COMMD1 and PtdIns(4,5)2 affect 268 ATP7B trafficking. Expression of the PLCd PH domain (fused to GFP) had no significant effect 269
on ATP7B localization with the lysosome and no significant effect on localization with the trans-270
Golgi under high copper conditions (Fig. 8D-F,J-L) . However, overexpression of PH-GFP 271 resulted in an ATP7B:TGN M2 (Fig. 8H) that was significantly higher than the control non-272 transfected cells, indicating that the distribution of the ATP7B pool had shifted towards the 273 trans-Golgi, supporting a role for PtdIns(4,5)P2 in ATP7B trafficking. The PH domain was 274 observed at intracellular vesicles and at the plasma membrane in these experiments with 275
HepG2 cells (Fig. 9 ). This indicates that PtdIns(4,5)2 may have a regulatory role at locations 276 other than the plasma membrane, consistent with the observation that COMMD1-PtdIns(4,5)P2 277 interaction is important for COMMD1 to modulate ATP7B location. retrieval suggests that the WASH complex is first recruited to the EE, which then recruits the 288 CCC complex through interactions with the FAM21 tail. From here, the CCC complex can then 289 recruit the "retromer-like" complex retriever, which then interacts with SNX17 and its bound 290 cargo, leading to retrieval of the cargo from degradation (see McNally and Cullen, 2018 for an 291 in-depth review (McNally and Cullen, 2018) ). Moreover, COMMD1's specific function in ATP7B 292 trafficking and thus in maintaining cellular copper homeostasis was until now elusive. However, 293 the broader impacts of COMMD1-mediated trafficking for targets other than ATP7B are not fully 294 understood, as COMMD1 appears to function as a pleiotropic cargo-directing adaptor. 295
Our current study determined that COMMD1 attenuation in HepG2 cells reduces the 296 amount of ATP7B at the lysosome and TGN when trafficking is induced by high copper 297
conditions (Figs. 2,3) . Additionally, COMMD1 attenuation leads to ATP7B accumulation in the 298 EE ( Fig. 4) and an overall increase in ATP7B abundance (Fig. 5) . Taken together, COMMD1 299 functions to ensure fidelity of ATP7B recycling or trafficking to the lysosome. Since ATP7B is 300 directed to the cytoplasmic surface of the lysosome (Polishchuk et al., 2014), consistent with our 301 observations (Fig. 10) , this targeting is not for degradation but to function in copper 302 sequestration. 303 with the lysosome increased when copper levels were increased (Fig. 1) . Under high copper 308
conditions the cell must continue to produce cuproproteins while simultaneously managing and 309 sequestering the excess copper load. It is likely the cell is upregulating ATP7B under these 310 conditions and the additional ATP7B is directed to the lysosome. The data herein inform a 311 model where ATP7B functions at the TGN for biosynthesis of cuproporteins and at the surface 312 of the lysosome for sequestration of excess copper. In this model, ATP7B traffics between the 313 TGN, the EE and the lysosome and its distribution is regulated at the EE by COMMD1 and its 314 interaction with PtdIns(4,5)P2 (Fig. 11) . 315
Prior studies reported that COMMD1 interacts with phosphatidylinositols with a strong 316 preference for PtdIns(4,5)P2 and to a lesser degree with PtdIns(4)P and PA (Burkhead et al., 317 2009). Other recent work suggested that COMMD1 binds non-specifically to negatively-charged 318 phospholipids (Healy et al., 2018). However, our current experiments find that attenuation of 319 COMMD1's interaction with PtdIns(4,5)P2 results in altered ATP7B trafficking (Fig. 6) , 320 supporting a distinct role for PtdIns(4,5)P2 in COMMD1-modulated trafficking. Specifically, 321 overexpression of wildtype COMMD1 appears to direct ATP7B away from the lysosome. 322
Whereas expression of the mutant variants, with decreased ability to bind PtdIns(4,5)P2, 323 reduces the amount at the TGN. It may be that the interaction with PtdIns(4,5)P2 acts as the 324 decision-making switch that directs ATP7B to the TGN or to function at the lysosome. Curiously, 325 a current paradigm suggests that PtdIns(4,5)P2 is indicative of the PM and related processes 326 (Balla, 2013) . However, our observations with respect to COMMD1-mediated trafficking as well 327
as the observation of PLCd PH domain in association numerous intracellular vesicles suggests 328 a broader cellular role. The impact of PLCd PH on ATP7B trafficking is also suggestive of a 329 specific role for this lipid in ATP7B trafficking, likely through COMMD1 action (Fig. 8) . Thus, in 330 addition to the PM-related signaling, PtdIns(4,5)P2 may function as an important regulator at 331 locations that include PM-derived components such as the EE. Taken together, this work begins 332
to answer the question of how the cell maintains trafficking fidelity of ATP7B (through COMMD1 333 PtdIns(4,5)P2) and reveals a cellular and biochemical mechanistic model for COMMD function in 334 cells. Though additional trafficking components have been identified in other studies, this work 335 establishes a mechanism of action for COMMD1 and PtdIns in maintenance of cellular 336 trafficking itineraries. 337
From a technical standpoint, this work emphasizes the importance of quantitative methods in 338 studies of membrane protein trafficking. Here, an application is presented that illustrates the 339 utility of quantitative immunofluorescence microscopy and statistical analysis. Additionally, these 340 results demonstrate that our quantitative methods provide a refined view of subcellular protein 341 distribution. 342
343
MATERIALS AND METHODS 344
Cell culture, plasmid transfection and copper treatment 345
Tet-on HepG2 cells (Clontech-Takara) were seeded on poly-lysine coated glass cover 346 slips in 12-well plates at 0.7x10 5 cells/well and grown in MEM/EBSS with 10% FBS and 347 penicillin/streptomycin at 37°C with 5% CO2. Cells were then incubated for two days then 348 transfected with specified plasmids or siRNA using TurboFect Secondary antibodies were conjugated to Alexa 488 and 647 (Invitrogen, Carlsbad, CA) and 388
Dylight 550 (Novus Biologicals, Littleton, CO). 389
Immunofluorescence staining 390
Cells grown on lysine-coated circle coverslips were fixed in cold 4% paraformaldehyde in 391 PBS for 20 minutes in the dark, followed by blocking and permeabilization in BP buffer (3% 392 BSA, 50mM NH4Cl, 0.1% Saponin in PBS with sodium azide) at 4°C overnight. Cells were then 393 incubated with primary antibodies diluted in BP buffer for two hours at room temperature in a 394 dark humidified chamber. After three 10-minute washes in BP buffer, the cells were incubated in 395 secondary antibodies diluted in BP buffer for 45 minutes at room temperature in a dark 396 humidified chamber. This was followed by three washes in BP buffer, a 10-minute incubation in 397 DAPI diluted 1:1000 in PBS, and two final washes in PBS. Cover slips were then rinsed in water 398 and mounted to slides with Fluoromount-G (Southern Biotech). 399
Immunofluorescence microscopy and 3D deconvolution 400
Cells were imaged using a Leica DM6000 widefield microscope with a 63x 1.40 -0.60 oil 401 objective and Photometrics CoolSNAP MYO CCD camera. Cells with intact nuclei were selected 402 for imaging. For cells expressing GFP constructs, GFP expression was assessed and only cells 403 with moderate expression and intact nuclei were imaged. Images were acquired as four channel 404 16-bit 1940x1460 (0.072 x 0.072 µm pixels) stacks of 12-14 image slices with z-steps of 405 0.198µm. Image stacks were then deconvolved using LAS-X 3D deconvolution using 10 406 iterations, an automatically generated point spread function, background removal, and intensity 407 rescaling to compensate for any bleaching that occurred during image acquisition of the stack. 408
Colocalization and statistical analysis 409
The deconvolved image stacks were analyzed with Huygens Professional (Scientific 410 Volume Imaging) for colocalization analysis. ROI masks were created for each image to select 411 cells of interest. Background for the two channels of interest was estimated using Huygens 412
Optimized method, which is a variation of Costes method but uses the entire histogram rather 413 than the linear regression line to iteratively determine the background level. Pearson and 414
Manders M1 and M2 correlation coefficients were then generated for each ROI. 
422
Pearson's correlation is used to measure the degree to which a linear relationship can 423 be used to explain the variability in pixel intensity in the red and green channels. Thus, Pearson 424 is a useful measure of association in a biological system when the relationship between the two 425 probes is linear (Dunn et al., 2011). Here we use Pearson to compare the degree to which 426 probe association changes from one treatment to the next. 427
The Manders coefficient is a more direct and intuitive measure of the fraction of one 428 protein that colocalizes with a second protein. Manders generates two coefficients for an image 429 consisting of both a red and a green channel; M1 is the fraction of pixels in R that colocalize 430 with pixels in G independent of intensity, and M2 is the fraction of pixels in G that colocalize with 431 pixels in R independent of intensity. These values are calculated as: It is important to note that Manders values are calculated independently of the probes' 437 intensities and therefore strictly measures co-occurrence(Dunn et al., 2011). For our purposes, 438 the 'green' channel (G) will represent ATP7B and the 'red' (R) channel will represent the probe 439 we are measuring against (TGN, lysosome or VPS35). 440
We used JMP Pro 13 (SAS Institute) for statistical analysis. Power analysis based on 441 preliminary experiments was used to determine an appropriate sample size. For each treatment, 442
